Literature DB >> 17109734

Prolonged function of macrophage, von Willebrand factor-deficient porcine pulmonary xenografts.

E Cantu1, K R Balsara, B Li, C Lau, S Gibson, A Wyse, K Baig, J Gaca, G V Gonzalez-Stawinski, T Nichols, W Parker, R D Davis.   

Abstract

Porcine von Willebrand factor (vWF) activates human and primate platelets. Having determined the importance of pulmonary intravascular macrophages (PIMs) in pulmonary xenotransplantation, we evaluated whether, in the absence of PIMs, vWF might play a role in pulmonary xenograft dysfunction. Utilizing a left single-lung transplant model, baboons depleted of anti-alphaGal antibodies received lungs from either vWF-deficient (n = 2); MCP-expressing (n = 5); MCP PIM-depleted (n = 5); or vWF-deficient PIM-depleted swine (n = 3). Two out of three of the PIM-depleted, pvWF deficient grafts survived longer than any previously reported pulmonary xenografts, including PIM-depleted xenografts expressing human complement regulatory proteins. Depletion of PIM's from vWF-deficient lungs, like depletion of PIM's from hMCP lungs, resulted in abrogation of the coagulopathy associated with pulmonary xenotransplantation. Thus, in terms of pulmonary graft survival, control of adverse reactions involving pvWF appears to be equally or even more important than is complement regulation using hMCP expression. However, based on the rapid failure of PIM-sufficient, pvWF-deficient pulmonary xenografts, pVWF-deficient pulmonary xenografts appear to be particularly sensitive to macrophage-mediated damage. These data provide initial evidence that vWF plays a role in the 'delayed' (24 h) dysfunction observed in pulmonary xenotransplantation using PIM depleted hMCP organs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17109734     DOI: 10.1111/j.1600-6143.2006.01603.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  22 in total

1.  Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation.

Authors:  C C Lin; M Ezzelarab; R Shapiro; B Ekser; C Long; H Hara; G Echeverri; C Torres; H Watanabe; D Ayares; A Dorling; D K C Cooper
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

2.  A brief history of cross-species organ transplantation.

Authors:  David K C Cooper
Journal:  Proc (Bayl Univ Med Cent)       Date:  2012-01

Review 3.  Which anti-platelet therapies might be beneficial in xenotransplantation?

Authors:  Moritz Schmelzle; Peter J Cowan; Simon C Robson
Journal:  Xenotransplantation       Date:  2011 Mar-Apr       Impact factor: 3.907

Review 4.  The need for xenotransplantation as a source of organs and cells for clinical transplantation.

Authors:  Burcin Ekser; David K C Cooper; A Joseph Tector
Journal:  Int J Surg       Date:  2015-07-16       Impact factor: 6.071

Review 5.  Clinical lung xenotransplantation--what donor genetic modifications may be necessary?

Authors:  David K C Cooper; Burcin Ekser; Christopher Burlak; Mohamed Ezzelarab; Hidetaka Hara; Leela Paris; A Joseph Tector; Carol Phelps; Agnes M Azimzadeh; David Ayares; Simon C Robson; Richard N Pierson
Journal:  Xenotransplantation       Date:  2012 May-Jun       Impact factor: 3.907

Review 6.  Lung xenotransplantation.

Authors:  Hisashi Sahara; Hironosuke Watanabe; Thomas Pomposelli; Kazuhiko Yamada
Journal:  Curr Opin Organ Transplant       Date:  2017-12       Impact factor: 2.640

7.  GalT-KO pig lungs are highly susceptible to acute vascular rejection in baboons, which may be mitigated by transgenic expression of hCD47 on porcine blood vessels.

Authors:  Hironosuke Watanabe; Hisashi Sahara; Shunichiro Nomura; Tatsu Tanabe; Dilrukshi K Ekanayake-Alper; Lennan K Boyd; Nathan J Louras; Arsenoi Asfour; Makenzie A Danton; Siu-Hong Ho; Scott J Arn; Robert J Hawley; Akira Shimizu; Takeshi Nagayasu; David Ayares; Marc I Lorber; Megan Sykes; David H Sachs; Kazuhiko Yamada
Journal:  Xenotransplantation       Date:  2018-03-12       Impact factor: 3.907

Review 8.  Lung xenotransplantation: recent progress and current status.

Authors:  Donald G Harris; Kevin J Quinn; Siamak Dahi; Lars Burdorf; Agnes M Azimzadeh; Richard N Pierson
Journal:  Xenotransplantation       Date:  2014-07-05       Impact factor: 3.907

Review 9.  Immunobiology of liver xenotransplantation.

Authors:  Burcin Ekser; Christopher Burlak; Joshua P Waldman; Andrew J Lutz; Leela L Paris; Massimiliano Veroux; Simon C Robson; Michael A Rees; David Ayares; Bruno Gridelli; A Joseph Tector; David Kc Cooper
Journal:  Expert Rev Clin Immunol       Date:  2012-09       Impact factor: 4.473

10.  Comparative biology of decellularized lung matrix: Implications of species mismatch in regenerative medicine.

Authors:  Jenna L Balestrini; Ashley L Gard; Kristin A Gerhold; Elise C Wilcox; Angela Liu; Jonas Schwan; Andrew V Le; Pavlina Baevova; Sashka Dimitrievska; Liping Zhao; Sumati Sundaram; Huanxing Sun; Laure Rittié; Rachel Dyal; Tom J Broekelmann; Robert P Mecham; Martin A Schwartz; Laura E Niklason; Eric S White
Journal:  Biomaterials       Date:  2016-06-16       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.